New shot aims to ease pain for days after bunion surgery

NCT ID NCT07574385

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a new long-acting painkiller called ALX006 for pain after bunion surgery. About 60 adults will receive a single nerve block shot of either ALX006 or a standard painkiller. The goal is to see if ALX006 provides longer pain relief with fewer side effects.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

ALX006 (extended-release bupivacaine)

What this could lead to

If it works, this could provide longer-lasting pain relief after foot surgery with fewer injections.

What could go wrong

This is an early Phase 2 trial with only 60 people, so results may not apply widely. The drug may cause side effects or not work better than standard care.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HALLUX VALGUS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

agnosia Hallux Valgus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • CenExel Salt Lake City

    RECRUITING

    Millcreek, Utah, 84107, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact